Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway

PURPOSE: In this study, we aimed to investigate the effect of follistatin (FST) on hepatic steatosis in NAFLD and the underlying mechanism, which has rarely been reported before. METHODS: Liver samples from NAFLD patients and normal liver samples (from liver donors) were collected to investigate hep...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Junlu, Cong, Li, Jia, Yingbin, He, Bai-Liang, Guo, Yifan, He, Jianzhong, Li, Decheng, Zou, Baojia, Li, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621035/
https://www.ncbi.nlm.nih.gov/pubmed/36325432
http://dx.doi.org/10.2147/DMSO.S380053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621035/
https://www.ncbi.nlm.nih.gov/pubmed/36325432
http://dx.doi.org/10.2147/DMSO.S380053

Ejemplares similares